Clinical Trial Update: Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001) [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of Broad Spectrum HPV Vaccine (V502-001) completed; the trial evaluated the vaccine across HPV-related conditions including cervical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts
• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Broad Spectrum HPV Vaccine

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HPV, Cervical Cancer | Phase 2 | Status: COMPLETED